Eliem Therapeutics, Inc - stock earnings
ELYM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.0 million USD | ? USD |
| 2023Q2 | -5.2 million USD | ? USD |
| 2023Q1 | -21.1 million USD | ? USD |
| 2022Q4 | -6.0 million USD | ? USD |
| 2022Q3 | -10.6 million USD | ? USD |
| 2022Q2 | -15.5 million USD | ? USD |
| 2022Q1 | -13.3 million USD | ? USD |
| 2021Q4 | -10.5 million USD | ? USD |
| 2021Q3 | -9.6 million USD | ? USD |
| 2021Q2 | -8.7 million USD | ? USD |
| 2021Q1 | -18.6 million USD | ? USD |
| 2020Q4 | -14.9 million USD | ? USD |
| 2020Q3 | -2.3 million USD | ? USD |
| 2020Q2 | -1.6 million USD | ? USD |
| 2020Q1 | -1.9 million USD | ? USD |
ELYM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -39.2 million USD | ? USD |
| 2022 | -45.4 million USD | ? USD |
| 2021 | -47.5 million USD | ? USD |
| 2020 | -11.5 million USD | ? USD |
| 2019 | -3.8 million USD | ? USD |
ELYM
Price: $7.57
52 week price:
Earnings Per Share: -1.30 USD
P/E Ratio: -1.85
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 3200
Market Capitalization: 119.5 million